Personalized EEG-guided brain stimulation targeting in major depression via network controllability and multi-objective optimization

Background Major depressive disorder (MDD) is associated with widespread disruptions in brain network dynamics. Although noninvasive brain stimulation (NIBS) has shown promise as an alternative treatment, its efficacy remains limited due to a lack of individualized targeting strategies that account...

Celý popis

Uložené v:
Podrobná bibliografia
Vydané v:BMC psychiatry Ročník 25; číslo 1; s. 723 - 11
Hlavní autori: Wang, Aihua, Sun, Jingnan
Médium: Journal Article
Jazyk:English
Vydavateľské údaje: London BioMed Central 23.07.2025
BioMed Central Ltd
Springer Nature B.V
BMC
Predmet:
ISSN:1471-244X, 1471-244X
On-line prístup:Získať plný text
Tagy: Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
Abstract Background Major depressive disorder (MDD) is associated with widespread disruptions in brain network dynamics. Although noninvasive brain stimulation (NIBS) has shown promise as an alternative treatment, its efficacy remains limited due to a lack of individualized targeting strategies that account for functional and topological heterogeneity in brain networks. Methods This study developed a novel EEG-based framework to personalize NIBS strategies in MDD. Resting-state EEG data from 30 healthy controls and 34 MDD patients were analyzed. Functional connectivity was estimated across five frequency bands using phase locking value (PLV), amplitude envelope correlation (AEC), and weighted phase lag index (wPLI). Spectral graph embedding and structural controllability theory were applied to identify candidate stimulation targets. A multi-objective optimization algorithm (NSGA-II) was used to select optimal node–frequency–amplitude combinations minimizing control energy while maximizing network efficiency gain and structural restoration. Kuramoto-based neural simulations were conducted to evaluate stimulation efficacy in silico, quantifying changes in global synchrony, modularity, and local efficiency. Results MDD patients exhibited hyperconnectivity in PLV and AEC and reduced wPLI compared to controls. Control nodes in MDD were more centrally distributed, particularly around Cz in alpha and beta bands. NSGA-II optimization yielded subject-specific stimulation strategies with favorable trade-offs. Simulated stimulation significantly enhanced global synchrony (median R  = 0.68, SD = 0.30), reduced network modularity (median ΔQ = − 0.0017, SD = 2.93), and improved local efficiency (median ΔEff = 0.0158, SD = 0.0038). Individualized stimulation plans consistently outperformed random controls in restoring network-level metrics. Conclusions The proposed framework enables data-driven, mathematically interpretable, and simulation-validated planning of personalized brain stimulation strategies for MDD. These findings highlight the potential of EEG-based network analysis and multi-objective optimization in guiding precision neuromodulation interventions.
AbstractList Background Major depressive disorder (MDD) is associated with widespread disruptions in brain network dynamics. Although noninvasive brain stimulation (NIBS) has shown promise as an alternative treatment, its efficacy remains limited due to a lack of individualized targeting strategies that account for functional and topological heterogeneity in brain networks. Methods This study developed a novel EEG-based framework to personalize NIBS strategies in MDD. Resting-state EEG data from 30 healthy controls and 34 MDD patients were analyzed. Functional connectivity was estimated across five frequency bands using phase locking value (PLV), amplitude envelope correlation (AEC), and weighted phase lag index (wPLI). Spectral graph embedding and structural controllability theory were applied to identify candidate stimulation targets. A multi-objective optimization algorithm (NSGA-II) was used to select optimal node-frequency-amplitude combinations minimizing control energy while maximizing network efficiency gain and structural restoration. Kuramoto-based neural simulations were conducted to evaluate stimulation efficacy in silico, quantifying changes in global synchrony, modularity, and local efficiency. Results MDD patients exhibited hyperconnectivity in PLV and AEC and reduced wPLI compared to controls. Control nodes in MDD were more centrally distributed, particularly around Cz in alpha and beta bands. NSGA-II optimization yielded subject-specific stimulation strategies with favorable trade-offs. Simulated stimulation significantly enhanced global synchrony (median R = 0.68, SD = 0.30), reduced network modularity (median [DELA]Q = - 0.0017, SD = 2.93), and improved local efficiency (median [DELA]Eff = 0.0158, SD = 0.0038). Individualized stimulation plans consistently outperformed random controls in restoring network-level metrics. Conclusions The proposed framework enables data-driven, mathematically interpretable, and simulation-validated planning of personalized brain stimulation strategies for MDD. These findings highlight the potential of EEG-based network analysis and multi-objective optimization in guiding precision neuromodulation interventions. Keywords: Major depressive disorder, EEG, Brain network controllability, Personalized stimulation
Major depressive disorder (MDD) is associated with widespread disruptions in brain network dynamics. Although noninvasive brain stimulation (NIBS) has shown promise as an alternative treatment, its efficacy remains limited due to a lack of individualized targeting strategies that account for functional and topological heterogeneity in brain networks. This study developed a novel EEG-based framework to personalize NIBS strategies in MDD. Resting-state EEG data from 30 healthy controls and 34 MDD patients were analyzed. Functional connectivity was estimated across five frequency bands using phase locking value (PLV), amplitude envelope correlation (AEC), and weighted phase lag index (wPLI). Spectral graph embedding and structural controllability theory were applied to identify candidate stimulation targets. A multi-objective optimization algorithm (NSGA-II) was used to select optimal node-frequency-amplitude combinations minimizing control energy while maximizing network efficiency gain and structural restoration. Kuramoto-based neural simulations were conducted to evaluate stimulation efficacy in silico, quantifying changes in global synchrony, modularity, and local efficiency. MDD patients exhibited hyperconnectivity in PLV and AEC and reduced wPLI compared to controls. Control nodes in MDD were more centrally distributed, particularly around Cz in alpha and beta bands. NSGA-II optimization yielded subject-specific stimulation strategies with favorable trade-offs. Simulated stimulation significantly enhanced global synchrony (median R = 0.68, SD = 0.30), reduced network modularity (median ΔQ = - 0.0017, SD = 2.93), and improved local efficiency (median ΔEff = 0.0158, SD = 0.0038). Individualized stimulation plans consistently outperformed random controls in restoring network-level metrics. The proposed framework enables data-driven, mathematically interpretable, and simulation-validated planning of personalized brain stimulation strategies for MDD. These findings highlight the potential of EEG-based network analysis and multi-objective optimization in guiding precision neuromodulation interventions.
Background Major depressive disorder (MDD) is associated with widespread disruptions in brain network dynamics. Although noninvasive brain stimulation (NIBS) has shown promise as an alternative treatment, its efficacy remains limited due to a lack of individualized targeting strategies that account for functional and topological heterogeneity in brain networks. Methods This study developed a novel EEG-based framework to personalize NIBS strategies in MDD. Resting-state EEG data from 30 healthy controls and 34 MDD patients were analyzed. Functional connectivity was estimated across five frequency bands using phase locking value (PLV), amplitude envelope correlation (AEC), and weighted phase lag index (wPLI). Spectral graph embedding and structural controllability theory were applied to identify candidate stimulation targets. A multi-objective optimization algorithm (NSGA-II) was used to select optimal node–frequency–amplitude combinations minimizing control energy while maximizing network efficiency gain and structural restoration. Kuramoto-based neural simulations were conducted to evaluate stimulation efficacy in silico, quantifying changes in global synchrony, modularity, and local efficiency. Results MDD patients exhibited hyperconnectivity in PLV and AEC and reduced wPLI compared to controls. Control nodes in MDD were more centrally distributed, particularly around Cz in alpha and beta bands. NSGA-II optimization yielded subject-specific stimulation strategies with favorable trade-offs. Simulated stimulation significantly enhanced global synchrony (median R  = 0.68, SD = 0.30), reduced network modularity (median ΔQ = − 0.0017, SD = 2.93), and improved local efficiency (median ΔEff = 0.0158, SD = 0.0038). Individualized stimulation plans consistently outperformed random controls in restoring network-level metrics. Conclusions The proposed framework enables data-driven, mathematically interpretable, and simulation-validated planning of personalized brain stimulation strategies for MDD. These findings highlight the potential of EEG-based network analysis and multi-objective optimization in guiding precision neuromodulation interventions.
Abstract Background Major depressive disorder (MDD) is associated with widespread disruptions in brain network dynamics. Although noninvasive brain stimulation (NIBS) has shown promise as an alternative treatment, its efficacy remains limited due to a lack of individualized targeting strategies that account for functional and topological heterogeneity in brain networks. Methods This study developed a novel EEG-based framework to personalize NIBS strategies in MDD. Resting-state EEG data from 30 healthy controls and 34 MDD patients were analyzed. Functional connectivity was estimated across five frequency bands using phase locking value (PLV), amplitude envelope correlation (AEC), and weighted phase lag index (wPLI). Spectral graph embedding and structural controllability theory were applied to identify candidate stimulation targets. A multi-objective optimization algorithm (NSGA-II) was used to select optimal node–frequency–amplitude combinations minimizing control energy while maximizing network efficiency gain and structural restoration. Kuramoto-based neural simulations were conducted to evaluate stimulation efficacy in silico, quantifying changes in global synchrony, modularity, and local efficiency. Results MDD patients exhibited hyperconnectivity in PLV and AEC and reduced wPLI compared to controls. Control nodes in MDD were more centrally distributed, particularly around Cz in alpha and beta bands. NSGA-II optimization yielded subject-specific stimulation strategies with favorable trade-offs. Simulated stimulation significantly enhanced global synchrony (median R = 0.68, SD = 0.30), reduced network modularity (median ΔQ = − 0.0017, SD = 2.93), and improved local efficiency (median ΔEff = 0.0158, SD = 0.0038). Individualized stimulation plans consistently outperformed random controls in restoring network-level metrics. Conclusions The proposed framework enables data-driven, mathematically interpretable, and simulation-validated planning of personalized brain stimulation strategies for MDD. These findings highlight the potential of EEG-based network analysis and multi-objective optimization in guiding precision neuromodulation interventions.
Major depressive disorder (MDD) is associated with widespread disruptions in brain network dynamics. Although noninvasive brain stimulation (NIBS) has shown promise as an alternative treatment, its efficacy remains limited due to a lack of individualized targeting strategies that account for functional and topological heterogeneity in brain networks. This study developed a novel EEG-based framework to personalize NIBS strategies in MDD. Resting-state EEG data from 30 healthy controls and 34 MDD patients were analyzed. Functional connectivity was estimated across five frequency bands using phase locking value (PLV), amplitude envelope correlation (AEC), and weighted phase lag index (wPLI). Spectral graph embedding and structural controllability theory were applied to identify candidate stimulation targets. A multi-objective optimization algorithm (NSGA-II) was used to select optimal node-frequency-amplitude combinations minimizing control energy while maximizing network efficiency gain and structural restoration. Kuramoto-based neural simulations were conducted to evaluate stimulation efficacy in silico, quantifying changes in global synchrony, modularity, and local efficiency. MDD patients exhibited hyperconnectivity in PLV and AEC and reduced wPLI compared to controls. Control nodes in MDD were more centrally distributed, particularly around Cz in alpha and beta bands. NSGA-II optimization yielded subject-specific stimulation strategies with favorable trade-offs. Simulated stimulation significantly enhanced global synchrony (median R = 0.68, SD = 0.30), reduced network modularity (median [DELA]Q = - 0.0017, SD = 2.93), and improved local efficiency (median [DELA]Eff = 0.0158, SD = 0.0038). Individualized stimulation plans consistently outperformed random controls in restoring network-level metrics. The proposed framework enables data-driven, mathematically interpretable, and simulation-validated planning of personalized brain stimulation strategies for MDD. These findings highlight the potential of EEG-based network analysis and multi-objective optimization in guiding precision neuromodulation interventions.
BackgroundMajor depressive disorder (MDD) is associated with widespread disruptions in brain network dynamics. Although noninvasive brain stimulation (NIBS) has shown promise as an alternative treatment, its efficacy remains limited due to a lack of individualized targeting strategies that account for functional and topological heterogeneity in brain networks.MethodsThis study developed a novel EEG-based framework to personalize NIBS strategies in MDD. Resting-state EEG data from 30 healthy controls and 34 MDD patients were analyzed. Functional connectivity was estimated across five frequency bands using phase locking value (PLV), amplitude envelope correlation (AEC), and weighted phase lag index (wPLI). Spectral graph embedding and structural controllability theory were applied to identify candidate stimulation targets. A multi-objective optimization algorithm (NSGA-II) was used to select optimal node–frequency–amplitude combinations minimizing control energy while maximizing network efficiency gain and structural restoration. Kuramoto-based neural simulations were conducted to evaluate stimulation efficacy in silico, quantifying changes in global synchrony, modularity, and local efficiency.ResultsMDD patients exhibited hyperconnectivity in PLV and AEC and reduced wPLI compared to controls. Control nodes in MDD were more centrally distributed, particularly around Cz in alpha and beta bands. NSGA-II optimization yielded subject-specific stimulation strategies with favorable trade-offs. Simulated stimulation significantly enhanced global synchrony (median R = 0.68, SD = 0.30), reduced network modularity (median ΔQ = − 0.0017, SD = 2.93), and improved local efficiency (median ΔEff = 0.0158, SD = 0.0038). Individualized stimulation plans consistently outperformed random controls in restoring network-level metrics.ConclusionsThe proposed framework enables data-driven, mathematically interpretable, and simulation-validated planning of personalized brain stimulation strategies for MDD. These findings highlight the potential of EEG-based network analysis and multi-objective optimization in guiding precision neuromodulation interventions.
Major depressive disorder (MDD) is associated with widespread disruptions in brain network dynamics. Although noninvasive brain stimulation (NIBS) has shown promise as an alternative treatment, its efficacy remains limited due to a lack of individualized targeting strategies that account for functional and topological heterogeneity in brain networks.BACKGROUNDMajor depressive disorder (MDD) is associated with widespread disruptions in brain network dynamics. Although noninvasive brain stimulation (NIBS) has shown promise as an alternative treatment, its efficacy remains limited due to a lack of individualized targeting strategies that account for functional and topological heterogeneity in brain networks.This study developed a novel EEG-based framework to personalize NIBS strategies in MDD. Resting-state EEG data from 30 healthy controls and 34 MDD patients were analyzed. Functional connectivity was estimated across five frequency bands using phase locking value (PLV), amplitude envelope correlation (AEC), and weighted phase lag index (wPLI). Spectral graph embedding and structural controllability theory were applied to identify candidate stimulation targets. A multi-objective optimization algorithm (NSGA-II) was used to select optimal node-frequency-amplitude combinations minimizing control energy while maximizing network efficiency gain and structural restoration. Kuramoto-based neural simulations were conducted to evaluate stimulation efficacy in silico, quantifying changes in global synchrony, modularity, and local efficiency.METHODSThis study developed a novel EEG-based framework to personalize NIBS strategies in MDD. Resting-state EEG data from 30 healthy controls and 34 MDD patients were analyzed. Functional connectivity was estimated across five frequency bands using phase locking value (PLV), amplitude envelope correlation (AEC), and weighted phase lag index (wPLI). Spectral graph embedding and structural controllability theory were applied to identify candidate stimulation targets. A multi-objective optimization algorithm (NSGA-II) was used to select optimal node-frequency-amplitude combinations minimizing control energy while maximizing network efficiency gain and structural restoration. Kuramoto-based neural simulations were conducted to evaluate stimulation efficacy in silico, quantifying changes in global synchrony, modularity, and local efficiency.MDD patients exhibited hyperconnectivity in PLV and AEC and reduced wPLI compared to controls. Control nodes in MDD were more centrally distributed, particularly around Cz in alpha and beta bands. NSGA-II optimization yielded subject-specific stimulation strategies with favorable trade-offs. Simulated stimulation significantly enhanced global synchrony (median R = 0.68, SD = 0.30), reduced network modularity (median ΔQ = - 0.0017, SD = 2.93), and improved local efficiency (median ΔEff = 0.0158, SD = 0.0038). Individualized stimulation plans consistently outperformed random controls in restoring network-level metrics.RESULTSMDD patients exhibited hyperconnectivity in PLV and AEC and reduced wPLI compared to controls. Control nodes in MDD were more centrally distributed, particularly around Cz in alpha and beta bands. NSGA-II optimization yielded subject-specific stimulation strategies with favorable trade-offs. Simulated stimulation significantly enhanced global synchrony (median R = 0.68, SD = 0.30), reduced network modularity (median ΔQ = - 0.0017, SD = 2.93), and improved local efficiency (median ΔEff = 0.0158, SD = 0.0038). Individualized stimulation plans consistently outperformed random controls in restoring network-level metrics.The proposed framework enables data-driven, mathematically interpretable, and simulation-validated planning of personalized brain stimulation strategies for MDD. These findings highlight the potential of EEG-based network analysis and multi-objective optimization in guiding precision neuromodulation interventions.CONCLUSIONSThe proposed framework enables data-driven, mathematically interpretable, and simulation-validated planning of personalized brain stimulation strategies for MDD. These findings highlight the potential of EEG-based network analysis and multi-objective optimization in guiding precision neuromodulation interventions.
ArticleNumber 723
Audience Academic
Author Sun, Jingnan
Wang, Aihua
Author_xml – sequence: 1
  givenname: Aihua
  surname: Wang
  fullname: Wang, Aihua
  email: wangaihua@qymail.bhu.edu.cn
  organization: School of Mathematical Sciences, Bohai University
– sequence: 2
  givenname: Jingnan
  surname: Sun
  fullname: Sun, Jingnan
  organization: School of Biomedical Engineering, Tsinghua University
BackLink https://www.ncbi.nlm.nih.gov/pubmed/40702439$$D View this record in MEDLINE/PubMed
BookMark eNp9kk1v1DAQhiNURD_gD3BAkbhwSfFXYueEqmoplSrBASRulmM7wUtiL7aztD3zw5ndLW0XIWQpGc2881ivZ46LAx-8LYqXGJ1iLJq3CRMhRIVIXSGOOa6unxRHmEFAGPt68Cg-LI5TWiKEuajxs-KQIY4Io-1R8euTjSl4Nbpba8rF4qIaZmcg7KJyvkzZTfOosgu-zCoONjs_lFCY1DLE0thVtCltqmunSm_zzxC_lzr4HMM4qs6NLt-UypsSMNlVoVtand3almEFaHe7RT8vnvZqTPbF3f-k-PJ-8fn8Q3X18eLy_Oyq0nWDc1VjinvesbpBLXxVjbXuRS-4pqimLel5z5jhnRK4Uaa1jaaCIUUYFoQZ29CT4nLHNUEt5Sq6ScUbGZST20SIg1QxOz1aaWplKFKW1g2D14JrjGGEtL1RkBUKWO92rNXcTdZoC5bVuAfdr3j3TQ5hLTGBqVHKgfDmjhDDj9mmLCeXtIVn8zbMSVJCCa_hUJC-_ku6DHOEqW1VHKGGts2DalDgwPk-wMV6A5VngrWo5i0noDr9hwqOsZODydneQX6v4dVjp_cW_ywRCMhOoGNIKdr-XoKR3Gyq3G2qhE2V202V19BEd00JxH6w8cHSf7p-AxdD7bU
Cites_doi 10.3389/fncom.2022.729556
10.1016/j.biopsych.2023.11.013
10.1016/j.asoc.2014.12.032
10.1109/EMBC53108.2024.10782607
10.1371/journal.pcbi.1005076
10.1007/s11571-023-10041-5
10.1111/cns.70301
10.1038/s41746-024-01384-2
10.3389/fphar.2023.1207020
10.3928/00485713-20221018-02
10.1016/j.bspc.2023.104851
10.3390/brainsci12040472
10.1016/j.jad.2023.07.068
10.1088/1741-2552/ab0ab5
10.1016/j.brs.2017.11.016
10.1001/jamapsychiatry.2015.0071
10.1016/j.bspc.2024.106954
10.1016/j.bpsc.2017.07.001
10.1038/s41572-023-00454-1
10.1002/mco2.532
10.1109/tbme.2019.2913928
10.1016/j.brainres.2023.148282
10.1016/j.brs.2022.07.054
10.1038/s41514-023-00129-x
10.1016/j.neuroscience.2021.08.010
10.1371/journal.pone.0133775
10.1109/ALLERTON.2018.8636037
10.1038/ncomms3447
10.1093/sleep/zsad167
10.1186/s12916-024-03481-1
ContentType Journal Article
Copyright The Author(s) 2025
2025. The Author(s).
COPYRIGHT 2025 BioMed Central Ltd.
2025. This work is licensed under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
The Author(s) 2025 2025
Copyright_xml – notice: The Author(s) 2025
– notice: 2025. The Author(s).
– notice: COPYRIGHT 2025 BioMed Central Ltd.
– notice: 2025. This work is licensed under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: The Author(s) 2025 2025
DBID C6C
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7TK
7X7
7XB
88E
88G
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
DWQXO
FYUFA
GHDGH
GNUQQ
K9.
M0S
M1P
M2M
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
PSYQQ
Q9U
7X8
5PM
DOA
DOI 10.1186/s12888-025-07171-x
DatabaseName SpringerOpen
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Neurosciences Abstracts
ProQuest Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Psychology Database (Alumni)
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials Local Electronic Collection Information
ProQuest Central
ProQuest One
ProQuest Central
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
ProQuest Health & Medical Complete (Alumni)
Health & Medical Collection (Alumni Edition)
PML(ProQuest Medical Library)
Psychology Database
ProQuest Central Premium
ProQuest One Academic
Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic (retired)
ProQuest One Academic UKI Edition
One Psychology
ProQuest Central Basic
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Publicly Available Content Database
ProQuest One Psychology
ProQuest Central Student
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Central
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Health & Medical Research Collection
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest Central Basic
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Psychology Journals (Alumni)
Neurosciences Abstracts
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest Psychology Journals
ProQuest One Academic UKI Edition
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList
MEDLINE



Publicly Available Content Database
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: PIMPY
  name: Publicly Available Content Database
  url: http://search.proquest.com/publiccontent
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1471-244X
EndPage 11
ExternalDocumentID oai_doaj_org_article_d5ad30ae3564407f8fdd4229fda0ae8a
PMC12288337
A849057972
40702439
10_1186_s12888_025_07171_x
Genre Journal Article
GroupedDBID ---
0R~
23N
2WC
53G
5VS
6J9
7X7
88E
8FI
8FJ
AAFWJ
AAJSJ
AASML
ABDBF
ABIVO
ABUWG
ACGFO
ACGFS
ACIHN
ACPRK
ACUHS
ADBBV
ADRAZ
ADUKV
AEAQA
AENEX
AFKRA
AFPKN
AHBYD
AHMBA
AHYZX
ALMA_UNASSIGNED_HOLDINGS
AMKLP
AMTXH
AOIJS
AZQEC
BAPOH
BAWUL
BCNDV
BENPR
BFQNJ
BMC
BPHCQ
BVXVI
C6C
CCPQU
CS3
DIK
DWQXO
E3Z
EAD
EAP
EAS
EBD
EBLON
EBS
EMB
EMK
EMOBN
ESX
F5P
FYUFA
GNUQQ
GROUPED_DOAJ
GX1
HMCUK
HYE
IAO
IHR
INH
INR
IPY
ITC
KQ8
M1P
M2M
M~E
O5R
O5S
OK1
OVT
P2P
PGMZT
PHGZM
PHGZT
PIMPY
PJZUB
PPXIY
PQQKQ
PROAC
PSQYO
PSYQQ
PUEGO
RBZ
RNS
ROL
RPM
RSV
SMD
SOJ
SV3
TR2
TUS
UKHRP
W2D
WOQ
WOW
XSB
AAYXX
AFFHD
CITATION
ALIPV
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7TK
7XB
8FK
K9.
M48
PKEHL
PQEST
PQUKI
Q9U
7X8
5PM
ID FETCH-LOGICAL-c561t-5131f7b45609b45a51ccf8f87c305392f7f44d7ba816ad9e6c3840a241824de63
IEDL.DBID RSV
ISICitedReferencesCount 0
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=001536398000001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 1471-244X
IngestDate Fri Oct 03 12:52:26 EDT 2025
Tue Nov 04 02:02:43 EST 2025
Fri Sep 05 15:35:36 EDT 2025
Thu Oct 09 21:50:31 EDT 2025
Sat Nov 29 13:46:32 EST 2025
Sat Nov 29 10:31:36 EST 2025
Tue Jul 29 01:38:34 EDT 2025
Sat Nov 29 07:33:50 EST 2025
Sat Sep 06 07:21:54 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords Personalized stimulation
EEG
Brain network controllability
Major depressive disorder
Language English
License 2025. The Author(s).
Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c561t-5131f7b45609b45a51ccf8f87c305392f7f44d7ba816ad9e6c3840a241824de63
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
OpenAccessLink https://link.springer.com/10.1186/s12888-025-07171-x
PMID 40702439
PQID 3237006396
PQPubID 44775
PageCount 11
ParticipantIDs doaj_primary_oai_doaj_org_article_d5ad30ae3564407f8fdd4229fda0ae8a
pubmedcentral_primary_oai_pubmedcentral_nih_gov_12288337
proquest_miscellaneous_3232757573
proquest_journals_3237006396
gale_infotracmisc_A849057972
gale_infotracacademiconefile_A849057972
pubmed_primary_40702439
crossref_primary_10_1186_s12888_025_07171_x
springer_journals_10_1186_s12888_025_07171_x
PublicationCentury 2000
PublicationDate 2025-07-23
PublicationDateYYYYMMDD 2025-07-23
PublicationDate_xml – month: 07
  year: 2025
  text: 2025-07-23
  day: 23
PublicationDecade 2020
PublicationPlace London
PublicationPlace_xml – name: London
– name: England
PublicationTitle BMC psychiatry
PublicationTitleAbbrev BMC Psychiatry
PublicationTitleAlternate BMC Psychiatry
PublicationYear 2025
Publisher BioMed Central
BioMed Central Ltd
Springer Nature B.V
BMC
Publisher_xml – name: BioMed Central
– name: BioMed Central Ltd
– name: Springer Nature B.V
– name: BMC
References 7171_CR13
7171_CR14
A Craik (7171_CR6) 2019; 16
7171_CR16
RH Kaiser (7171_CR8) 2015; 72
7171_CR12
X Li (7171_CR11) 2023; 14
RFH Cash (7171_CR4) 2024; 95
S Pain (7171_CR15) 2023; 85
JA Clancy (7171_CR5) 2022; 52
I Pan (7171_CR17) 2015; 29
C Zrenner (7171_CR31) 2018; 11
AE Whitton (7171_CR27) 2018; 3
LG Bauer (7171_CR1) 2022; 16
7171_CR28
SF Zhang (7171_CR30) 2023; 340
7171_CR24
7171_CR25
7171_CR26
7171_CR20
JN Sun (7171_CR22) 2021; 478
7171_CR23
ZZ Yuan (7171_CR29) 2013; 4
L Li (7171_CR10) 2024; 18
B He (7171_CR7) 2019; 66
J Sun (7171_CR21) 2024; 7
KL Ray (7171_CR18) 2023; 1806
7171_CR3
7171_CR2
G Kong (7171_CR9) 2022; 15
7171_CR19
References_xml – volume: 16
  start-page: Article729556
  year: 2022
  ident: 7171_CR1
  publication-title: Front Comput Neurosci
  doi: 10.3389/fncom.2022.729556
– volume: 95
  start-page: 510
  issue: 6
  year: 2024
  ident: 7171_CR4
  publication-title: Biol Psychiatry
  doi: 10.1016/j.biopsych.2023.11.013
– volume: 29
  start-page: 328
  year: 2015
  ident: 7171_CR17
  publication-title: Appl Soft Comput
  doi: 10.1016/j.asoc.2014.12.032
– ident: 7171_CR20
  doi: 10.1109/EMBC53108.2024.10782607
– ident: 7171_CR14
  doi: 10.1371/journal.pcbi.1005076
– volume: 18
  start-page: 1671
  issue: 4
  year: 2024
  ident: 7171_CR10
  publication-title: Cogn Neurodyn
  doi: 10.1007/s11571-023-10041-5
– ident: 7171_CR12
  doi: 10.1111/cns.70301
– ident: 7171_CR23
  doi: 10.1038/s41746-024-01384-2
– volume: 14
  start-page: 1207020
  year: 2023
  ident: 7171_CR11
  publication-title: Front Pharmacol
  doi: 10.3389/fphar.2023.1207020
– volume: 52
  start-page: 456
  issue: 11
  year: 2022
  ident: 7171_CR5
  publication-title: Psychiatric Annals
  doi: 10.3928/00485713-20221018-02
– volume: 85
  start-page: 104851
  year: 2023
  ident: 7171_CR15
  publication-title: Biomed Signal Process Control
  doi: 10.1016/j.bspc.2023.104851
– ident: 7171_CR2
  doi: 10.3390/brainsci12040472
– volume: 340
  start-page: 113
  year: 2023
  ident: 7171_CR30
  publication-title: J Affect Disord
  doi: 10.1016/j.jad.2023.07.068
– volume: 16
  start-page: 031001
  issue: 3
  year: 2019
  ident: 7171_CR6
  publication-title: J Neural Eng
  doi: 10.1088/1741-2552/ab0ab5
– volume: 11
  start-page: 374
  issue: 2
  year: 2018
  ident: 7171_CR31
  publication-title: Brain Stimul
  doi: 10.1016/j.brs.2017.11.016
– volume: 72
  start-page: 603
  issue: 6
  year: 2015
  ident: 7171_CR8
  publication-title: Jama Psychiatry
  doi: 10.1001/jamapsychiatry.2015.0071
– ident: 7171_CR16
  doi: 10.1016/j.bspc.2024.106954
– volume: 3
  start-page: 50
  issue: 1
  year: 2018
  ident: 7171_CR27
  publication-title: Biol Psychiatry-Cognitive Neurosci Neuroimaging
  doi: 10.1016/j.bpsc.2017.07.001
– ident: 7171_CR13
  doi: 10.1038/s41572-023-00454-1
– ident: 7171_CR25
  doi: 10.1002/mco2.532
– volume: 66
  start-page: 2115
  issue: 7
  year: 2019
  ident: 7171_CR7
  publication-title: IEEE Trans Biomed Eng
  doi: 10.1109/tbme.2019.2913928
– volume: 1806
  start-page: 148282
  year: 2023
  ident: 7171_CR18
  publication-title: Brain Res
  doi: 10.1016/j.brainres.2023.148282
– volume: 15
  start-page: 1063
  issue: 5
  year: 2022
  ident: 7171_CR9
  publication-title: Brain Stimul
  doi: 10.1016/j.brs.2022.07.054
– ident: 7171_CR24
  doi: 10.1038/s41514-023-00129-x
– volume: 478
  start-page: 24
  year: 2021
  ident: 7171_CR22
  publication-title: Neuroscience
  doi: 10.1016/j.neuroscience.2021.08.010
– ident: 7171_CR28
  doi: 10.1371/journal.pone.0133775
– ident: 7171_CR3
  doi: 10.1109/ALLERTON.2018.8636037
– volume: 4
  start-page: 2447
  year: 2013
  ident: 7171_CR29
  publication-title: Nat Commun
  doi: 10.1038/ncomms3447
– ident: 7171_CR19
  doi: 10.1093/sleep/zsad167
– volume: 7
  start-page: 375
  issue: 1
  year: 2024
  ident: 7171_CR21
  publication-title: NPJ Digit Med
  doi: 10.1038/s41746-024-01384-2
– ident: 7171_CR26
  doi: 10.1186/s12916-024-03481-1
SSID ssj0017851
Score 2.4262564
Snippet Background Major depressive disorder (MDD) is associated with widespread disruptions in brain network dynamics. Although noninvasive brain stimulation (NIBS)...
Major depressive disorder (MDD) is associated with widespread disruptions in brain network dynamics. Although noninvasive brain stimulation (NIBS) has shown...
Background Major depressive disorder (MDD) is associated with widespread disruptions in brain network dynamics. Although noninvasive brain stimulation (NIBS)...
BackgroundMajor depressive disorder (MDD) is associated with widespread disruptions in brain network dynamics. Although noninvasive brain stimulation (NIBS)...
Abstract Background Major depressive disorder (MDD) is associated with widespread disruptions in brain network dynamics. Although noninvasive brain stimulation...
SourceID doaj
pubmedcentral
proquest
gale
pubmed
crossref
springer
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Publisher
StartPage 723
SubjectTerms Adult
Algorithms
Brain - physiopathology
Brain network controllability
Brain research
Case-Control Studies
Depressive Disorder, Major - physiopathology
Depressive Disorder, Major - therapy
EEG
Electroencephalography
Electroencephalography - methods
Embedding
Female
Frequency dependence
Humans
Major depressive disorder
Male
Mathematical optimization
Medicine
Medicine & Public Health
Mental depression
Mental disorders
Middle Aged
Nerve Net - physiopathology
Neural networks
Neuromodulation
Neurophysiology
Noninvasive brain stimulation for mental disorders
Optimization
Personalized stimulation
Precision Medicine - methods
Psychiatry
Psychotherapy
Research methodology
Time series
Transcranial magnetic stimulation
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3Nb9UwDLfQhBAXNL7LBgoSEgeI1jZpkh4HeoMDTDuAtFuUJim8aa9F72ManPnDcZL2sQ4hLlyqqknUxD_bsRXHBnjhipZ7mzdUCS8oF-igNKbkVLZV5WVhG-Ui0h_k8bE6Pa1PrpT6CjFhKT1wItyBq4xjufGswp07l61qneNlWbfO4FcVTaNc1qMzNZwfhJLz4xUZJQ5WqIWRI0Lp1uC_FPRysg3FbP1_6uQrm9L1gMlrp6ZxMzrahTuDFUkO0-zvwg3f3YNbH4dz8vvw82S0sX94R2azd_TLZu7wtQkVIQiK9WIo20VSKDj-hWDDwpz1S7KNju3IxdyQLkWKkyGq_Txl9v5OTOdIjEekfXOW9CbpUQMthqudD-Dz0ezT2_d0qLdALVpRa1oVrGhlgyZVXuPTVIW1SG8lLSoFtKNa2XLuZGNUIYyrvbAM3UNEFn0U7rxgD2Gn6zv_GIhTjFcW8Za1imNEHcoX5o2VzPKmyuDVSH79LaXV0NEdUUInsDSCpSNY-jKDNwGhbc-QEjt-QEbRA6PofzFKBi8DvjoILoJozXD_ACccUmDpQ8XrcDNXlhnsT3qiwNlp88ghehD4lWYlk9HcExk83zaHkSGIrfP9JvYpJZrHkmXwKDHUdkk445Abss5ATVhtsuZpSzf_GtOBF2WsGC0zeD1y5e95_Z2oT_4HUffgdpmkipZsH3bWy41_CjftxXq-Wj6LMvkLhWk9wA
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: ProQuest Central
  dbid: BENPR
  link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwEB5BixAX3o9AQUZC4gBWkziJnRNq0RYOsFohkHqzHNtpt2KTso-qcOaHM3aclBTBhUsUxY40znz-PBOPZwBemKTOrI4rKgpb0KxAB6VSaUZ5neeWJ7oSxmv6A59OxeFhOQs_3FYhrLLnRE_UptXuH_kuSxn362nx5vQbdVWj3O5qKKFxFbZdpjLE-fb-ZDr7NOwjuNLz_VEZUeyukI0RGa6Eq_NjEno-Wo581v4_ufm3xely4OSl3VO_KB3c-t_h3IabwRwlex1-7sAV29yF6x_Dhvs9-DnrjfUf1pDJ5B092swN3lautARBfliE-l-kiylHMQk2LNRJuyRDmG1DzuaKNF3IOQnh8V-7FOHfiWoM8YGNtK1OOgImLVLZIpwRvQ9fDiaf376noXAD1WiOrWmesKTmFdpmcYlXlSda16IWXCO7oEFW8zrLDK-USAplSltohn4mQgSdnczYgj2AraZt7CMgRrAs1wgcXgr_TlG6OohxpTnTWZVH8KrXnzzt8nNI79eIQnbalqht6bUtzyPYdyoeerrc2v5BuzySYapKkyvDYmVZjrZizFFwY7I0LWuj8KlQEbx0AJGOARAFWoWDDCiwy6Ul90RWuiO-PI1gZ9QTZ64eN_fYkIE5VvICGBE8H5rdmy4arrHtxvdJOdrZnEXwsEPkMCSU2CWZLCMQI6yOxjxuaebHPq94kvrS0zyC1z2sL-T6-0d9_O9hPIEbaTfhaMp2YGu93NincE2freer5bMwYX8ByMNL7A
  priority: 102
  providerName: ProQuest
Title Personalized EEG-guided brain stimulation targeting in major depression via network controllability and multi-objective optimization
URI https://link.springer.com/article/10.1186/s12888-025-07171-x
https://www.ncbi.nlm.nih.gov/pubmed/40702439
https://www.proquest.com/docview/3237006396
https://www.proquest.com/docview/3232757573
https://pubmed.ncbi.nlm.nih.gov/PMC12288337
https://doaj.org/article/d5ad30ae3564407f8fdd4229fda0ae8a
Volume 25
WOSCitedRecordID wos001536398000001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVADU
  databaseName: Open Access: BioMedCentral Open Access Titles
  customDbUrl:
  eissn: 1471-244X
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0017851
  issn: 1471-244X
  databaseCode: RBZ
  dateStart: 20010101
  isFulltext: true
  titleUrlDefault: https://www.biomedcentral.com/search/
  providerName: BioMedCentral
– providerCode: PRVAON
  databaseName: DOAJ Directory of Open Access Journals
  customDbUrl:
  eissn: 1471-244X
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0017851
  issn: 1471-244X
  databaseCode: DOA
  dateStart: 20010101
  isFulltext: true
  titleUrlDefault: https://www.doaj.org/
  providerName: Directory of Open Access Journals
– providerCode: PRVHPJ
  databaseName: ROAD: Directory of Open Access Scholarly Resources
  customDbUrl:
  eissn: 1471-244X
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0017851
  issn: 1471-244X
  databaseCode: M~E
  dateStart: 20010101
  isFulltext: true
  titleUrlDefault: https://road.issn.org
  providerName: ISSN International Centre
– providerCode: PRVPQU
  databaseName: Health & Medical Collection
  customDbUrl:
  eissn: 1471-244X
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0017851
  issn: 1471-244X
  databaseCode: 7X7
  dateStart: 20090101
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/healthcomplete
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: ProQuest Central
  customDbUrl:
  eissn: 1471-244X
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0017851
  issn: 1471-244X
  databaseCode: BENPR
  dateStart: 20090101
  isFulltext: true
  titleUrlDefault: https://www.proquest.com/central
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: ProQuest Psychology Database
  customDbUrl:
  eissn: 1471-244X
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0017851
  issn: 1471-244X
  databaseCode: M2M
  dateStart: 20090101
  isFulltext: true
  titleUrlDefault: https://www.proquest.com/psychology
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: Publicly Available Content Database
  customDbUrl:
  eissn: 1471-244X
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0017851
  issn: 1471-244X
  databaseCode: PIMPY
  dateStart: 20090101
  isFulltext: true
  titleUrlDefault: http://search.proquest.com/publiccontent
  providerName: ProQuest
– providerCode: PRVAVX
  databaseName: SpringerLINK
  customDbUrl:
  eissn: 1471-244X
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0017851
  issn: 1471-244X
  databaseCode: RSV
  dateStart: 20011201
  isFulltext: true
  titleUrlDefault: https://link.springer.com/search?facet-content-type=%22Journal%22
  providerName: Springer Nature
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnR3JbtQw9AlahHphXwJlZCQkDhCRxEnsHFs0BSRmNGLTcLIc2ylTdRI0SwWc-XCeHSeQAge4WCMvmme_xe_FbwF4pOMqNSoqQ56bPExzNFBKmaQhq7LMsFiVXDtMv2bTKZ_Pi5kPClt33u7dk6ST1I6tef5sjZIUsWrLr1obJA5Rc9zNbLYZa6O__dC_Hdhy8114zB_XDa4gl6n_d3n8y4V03lny3Iupu4iOrv7fFq7BFa94koOWUq7DBVPfgMsT_7R-E77POrX8m9FkPH4RHm8XGn-WtogEQUmw9JW-SOs9jn9McGApT5oV6R1qa3K2kKRuncuJd4Q_bZOBfyWy1sS5MIZNedKKWtKg0Fr6aNBb8P5o_O75y9CXaAgVKl6bMItpXLEStbCowFZmsVIVrzhTKEdQ9apYlaaalZLHudSFyRVFixKJAc2aVJuc3oaduqnNXSCa0zRTSCKs4G5NXtiKh1GpGFVpmQXwpMOa-Nxm4hDOguG5aA9W4MEKd7DiSwCHFrH9TJtF23U0q2PhmVLoTGoaSUMz1AojhoBrnSZJUWmJvVwG8NiShbC8jrhX0ocsIMA2a5Y44Glhg3lZEsD-YCbyqBoOd4QlvIxYC5pQ5jTEPICH_bBdaf3eatNs3ZyEoUbNaAB3Wjrst4QQ23SSRQB8QKGDPQ9H6sUnl0E8TlyRaRbA045Qf8L190O992_T78Ne0tJ6mNB92NmstuYBXFJnm8V6NYKLbM5cy0eweziezt6M3BcRbCfJBPtmryazjyPH3D8A77hIog
linkProvider Springer Nature
linkToHtml http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9QwEB6VgoAL70eggJFAHCDqxk5i54BQgS2tulv1UKTejGM7ZSs2KfsoLWd-D7-RsZNsSRHceuASrWInsp1vXuvxfADPTFTEVvfyUKQ2DeMUA5Rc0TjkRZJYHulcGP-lB3x7W-ztZTtL8LM9C-PSKlud6BW1qbT7j3yVUca9PU3fHH4NHWuU211tKTRqWGzZk28Ysk1fb77H7_uc0vX-7ruNsGEVCDX6CrMwiVhU8Bwdh16GV5VEWheiEFwj9NFbKHgRx4bnSkSpMplNNcMgCMePnnhsbMrwvRfgYoyW0DEmDOlwsWvhiO7bgzkiXZ2i7kccOsJYFzVF4XHH-HmOgD8twW-m8Gya5pm9Wm8C16__b4t3A641zjZZq6XjJizZ8hZcHjbpBLfhx04biny3hvT7H8L9-cjgz9wRZxDUfuOG3YzUGfO4LAQbxuqgmpBFEnFJjkaKlHVCPWmS_7_UBdBPiCoN8WmbYZUf1OaFVKiox80J2Dvw8VzW4C4sl1Vp7wMxgsWJRrHgmfDPpJljeezlmjMd50kAL1u8yMO6-oj0UZtIZY0uieiSHl3yOIC3DlKLnq5yuL9RTfZlo4ikSZRhPWVZgp5wj-PAjYkpzQqj8K5QAbxwgJROvyHqtGqOaeCAXaUwuSbizB1g5jSAlU5P1Eu629xiUTZ6cSpPgRjA00Wze9Ll-pW2mvs-lGMUwVkA92oJWEwJR-xKaGYBiI5sdObcbSlHn33V9Ih6Ym0ewKtWjE7H9fdFffDvaTyBKxu7w4EcbG5vPYSrtBb2kLIVWJ5N5vYRXNJHs9F08tirCgKfzlu8fgGraKWT
linkToPdf http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwEB6hgiouvB-BAkZC4gBRk9iJnWOBXUCU1YqXerMc2ylbsUm1jwo488MZ28nSFDggLqtVbEtj-_N4Rv5mBuCRSWtmdVLForBFzAp0UCqVsZjXeW55qith_E7v88lEHByU01NR_J7t3j9JhpgGl6WpWe0emzoccVHsLlGr4g67UqzOH0ljtCLPM_RkHKnr3ftPm3cEV3q-D5X547jBdeSz9v-um09dTmeJk2deT_2lNL78_9O5Apc6g5TsBQRdhXO2uQbbb7sn9-vwY9qb69-tIaPRy_hwPTP4t3LFJQhqiHlXAYwEVjkKQbBhro7aBdkQbRtyMlOkCaRz0hHkv4Qk4d-Iagzx1Ma4rY6CCiYtKrN5FyV6Az6ORx-ev4q70g2xRoNsFecpTWteoXWWlPir8lTrWtSCa9QvaJLVvGbM8EqJtFCmtIWm6GkiSNDdYcYW9CZsNW1jbwMxgrJcI3R4KfyYonSVEJNKc6pZlUfwpN9BeRwydEjv2YhChoWVuLDSL6z8GsEzt8mbni67tv_QLg5ld1ilyZWhibI0R2sx4Si4MSzLytoo_CpUBI8dRKTTAYgDrbpQBhTYZdOSe4KVLsiXZxHsDHri2dXD5h5kstMdS0kzyr3lWETwcNPsRjo-XGPbte-TcbS0OY3gVsDkZkoosUszWUYgBmgdzHnY0sw--8ziaeaLT_MInvag_SXX3xf1zr91fwDb0xdjuf968uYuXMwC7OOM7sDWarG29-CCPlnNlov7_iz_BHzxTW0
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Personalized+EEG-guided+brain+stimulation+targeting+in+major+depression+via+network+controllability+and+multi-objective+optimization&rft.jtitle=BMC+psychiatry&rft.au=Wang%2C+Aihua&rft.au=Sun%2C+Jingnan&rft.date=2025-07-23&rft.pub=BioMed+Central&rft.eissn=1471-244X&rft.volume=25&rft.issue=1&rft_id=info:doi/10.1186%2Fs12888-025-07171-x&rft.externalDocID=10_1186_s12888_025_07171_x
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1471-244X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1471-244X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1471-244X&client=summon